(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(oxazol-5-yl)propanoic acid, 97%, 100mg

(R)-3-Amino-3-(4-bromophenyl)propanoic acid hydrochloride, 95.0%, 1g

1-[4-(4-Methoxyphenoxy)butyl]piperazine, 1g

2-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoindolin-1-one, 97.0%, 250mg

N-methyl-1-[2-(2-thienyl)-1,3-thiazol-4-yl]methanamine, 95.0%, 1g

3,3-Dimethyl-7-nitro-2,3-dihydrobenzo[b][1,4]oxazepin-4(5h)-one, 95%, 1g

6-Bromo-4-chloroquinoline-3-carbaldehyde, 95.0%, 100mg

Benzyl Benzoate>99.0%(GC)500g

Methyl 4-(2,2-diethoxyethoxy)benzoate, 95+%, 1g

6-(TRIFLUOROMETHOXY)PYRIDIN-3-OL, 95.0%, 250mg

Obiettivo IOS corretto all'infinito di fase E-Plan EPLPHi S40x/0,65. Distanza di lavoro 0,78 mm

4-Bromo-2-cyanobenzaldehyde, 95.0%, 5g

Peptone ex soia, 1 kg